Results from PINNACLE-1 and PINNACLE-2 randomized double blind placebo controlled trials show Glycopyrrolate – Formoterol MDI 18/9.6 μg as more efficient than placebo and monocomponent MDIs with the same safety profile.
Source: ChestNet.org (Open Access)
Advertisements